Development of the guidelines

Mindframe for Alcohol and Other Drugs builds on the most recent research relevant to Australia, previous guidelines and existing knowledge from experts in a range of fields.

Mindframe received funding to begin the guidelines for Mindframe for Alcohol and Other Drugs investigation and development in 2017.

This was initiated through stakeholder mapping of the alcohol and other drugs sector in Australia and the establishment of the Mindframe for Alcohol and Other Drugs Advisory Group (MAODAG).

Established in September 2017, the MAODAG were consulted at key stages of the project for expert opinion around the development of the project.

Everymind would like to acknowledge the Mindframe for Alcohol and Other Drugs Advisory Group for supporting the development of Mindframe for Alcohol and Other Drugs. A full list of the Advisory Group can be found at the Mindframe website.

Mindframe also consulted and collaborated with other representatives during this development process including journalists, university educators and communications managers from the mental health and suicide prevention sector.

The Mindframe for Alcohol and Other Drugs guidelines were developed following an extensive review of the evidence, including a thematic analysis of qualitative content from consultation with advisory groups.

There was also a particular focus on content and feedback from the MAODAG and from existing AOD guidelines.

The guidelines will continue to be further refined through the results of the following:

A comprehensive survey of the community and sector (Media, AOD, health, education, researchers) Evaluation of guideline dissemination Ongoing reviews of literature

As part of these core guidelines, collateral will continue to be created by the Mindframe team, to support the media in implementation of the guidelines and via dissemination on the Mindframe website.